IP Library › Patent Application 13797749
Patent Application
App. No. 13/797,749

DIAGNOSTIC METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/797,749
Abstract

It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.

Claims (6)

1 - 15 . (canceled)

16 . An agent for the detection of HBP for use in determining whether or not an individual is at risk of developing severe sepsis.

17 . An agent according to claim 16 wherein the agent comprises an HBP-specific antibody.

18 - 21 . (canceled)

22 . A test kit for use in a method for determining whether or not an individual is at risk of developing severe sepsis, which test kit comprises an agent for the detection of HBP in an individual.

23 . The kit of claim 21 additionally comprising means for the measurement of the WBC in an individual.

Assignments (2)
CHANGE OF NAME Recorded Jan 6, 2020
From: HANSA MEDICAL AB
To: HANSA BIOPHARMA AB
Reel/Frame 051485/0654 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2013
From: BJORCK, LARS; CHRISTENSSON, BERTIL; HERWALD, HEIKO; LINDER, ADAM; AKESSON, PER
To: HANSA MEDICAL AB
Reel/Frame 029982/0926 →